Health

Menarini Receives FDA Orphan Drug Designation for SEL24/MEN1703, a first in class, dual PIM/FLT3 inhibitor for the Treatment of Acute Myeloid Leukemia

The Menarini Group announced today that the U.S. Food and Drug Administration (FDA) granted orphan drug designation (ODD) to SEL24/MEN1703 for the treatment of Acute Myeloid Leukemia (AML). SEL24/MEN1703 is a first-in-class, orally available, dual PIM/FLT3 inhibitor, in-licensed by Menarini from Ryvu Therapeutics, and currently investigated in the DIAMOND-01 trial as a single agent for […]

thaipr.net

5 พ.ย. 64

Associates of Cape Cod Inc. Announces the Release of its One Millionth Horseshoe Crab From its Species Sustainability Project

ACC proudly announces that it has achieved the release of its millionth juvenile horseshoe crab to the wild, as a result of its species sustainability project. The program is the first of its kind to release ecologically significant numbers of North American Horseshoe Crabs (NAHSC); it was initiated by the company in 2017 in the […]

thaipr.net

5 พ.ย. 64

New progress of studies on Lianhua Qingwen’s mechanism to fight against SARS-CoV-2

During the efforts to prevent and control the epidemic, “3 medicines and 3 prescriptions” are selected from traditional Chinese medicine in China, including the representative medicine “Lianhua Qingwen”, produced by Yiling pharmaceutical, which has been widely used during public epidemic prevention. In addition, with the increasing popularity of the drug, scientists have carried out a […]

thaipr.net

4 พ.ย. 64

Novavax Files COVID-19 Vaccine for Provisional Approval in New Zealand

– Submission to New Zealand’s Medsafe marks the first protein-based COVID-19 vaccine submitted for authorization to regulatory authorities in New Zealand – All modules required for regulatory review of Novavax vaccine, including CMC data, are now complete for Medsafe Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today…

thaipr.net

4 พ.ย. 64

Nautilus and Abcam Announce Strategic Partnership to Accelerate Exploration of the Proteome

As an element of Nautilus’ overall reagent development and sourcing strategy, the partnership aims to accelerate research and development, and provide customers with access to Abcam’s antibody development technology and expertise Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, and Abcam (AIM:ABC; NASDAQ:ABCM), a…

thaipr.net

3 พ.ย. 64

Diabetes is “a pandemic of unprecedented magnitude” now affecting one in 10 adults worldwide, reveals the International Diabetes Federation

New figures from the International Diabetes Federation reveal that 537 million adults around the globe are living with diabetes The International Diabetes Federation (IDF) has released new figures showing that 537 million adults are now living with diabetes worldwide — a rise of 16% (74 million) since the previous IDF estimates in 2019. Released in […]

thaipr.net

2 พ.ย. 64
1 … 90 91 92 93 94 … 128

Copyright © 2025 Dataxet Limited (บริษัท ดาต้าเซ็ต จำกัด). All Rights Reserved.